Q2 2024 Holdings
Filed 2024-08-13 | 25 holdings | $352.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Liberty Broadband Corp(LBRDK) | COM SER C | 530307305 | $109.3M | 1,994,510 | 31.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $28.3M | 729,464 | 8.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $25.8M | 189,272 | 7.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $24.0M | 638,352 | 6.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $23.2M | 54,028 | 6.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $21.0M | 132,835 | 6.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $17.1M | 388,835 | 4.9% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $15.3M | 574,378 | 4.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $14.7M | 905,384 | 4.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $14.6M | 1,776,728 | 4.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.9M | 256,449 | 3.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $13.4M | 542,762 | 3.8% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $10.5M | 1,605,346 | 3.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $8.9M | 433,471 | 2.5% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $6.2M | 707,404 | 1.7% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $5.5M | 961,251 | 1.5% |
| Churchill Capital Corp VII | *W EXP 02/29/202 | 17144M110 | $191.8K | 548,000 | 0.1% |
| Moneyhero Limited | *W EXP 09/13/202 | G6202B119 | $71.6K | 895,000 | 0.0% |
| Concord Acquisition Corp II | *W EXP 99/99/999 | 20607U116 | $44.9K | 408,333 | 0.0% |
| Swiftmerge Acquisition Corp | *W EXP 12/13/202 | G63836111 | $39.2K | 490,000 | 0.0% |
| Lakeshore Biopharma Co LTD | *W EXP 03/15/202 | G9845F117 | $33.4K | 489,999 | 0.0% |
| Calidi Biotherapeutics Inc | *W EXP 03/14/202 | 320703119 | $27.6K | 655,200 | 0.0% |
| Compass Digital Acquisition Corp(COMP) | *W EXP 09/29/202 | G2476C123 | $27.5K | 459,906 | 0.0% |
| Marblegate Acquisition Corp | *W EXP 08/31/202 | 56608A113 | $26.8K | 735,000 | 0.0% |
| Calidi Biotherapeutics Inc | COM NEW | 320703101 | $25.0K | 125,000 | 0.0% |